Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 24 , ISSUE 8 ( August, 2020 ) > List of Articles

CASE REPORT

Postpartum Polymyositis Following Intrauterine Fetal Death

Manmohan P Borse, Kumar V Anand, Manoj Kumar, Debasish Panda

Keywords : Creatine phosphokinase, Polymyositis, Postpartum

Citation Information : Borse MP, Anand KV, Kumar M, Panda D. Postpartum Polymyositis Following Intrauterine Fetal Death. Indian J Crit Care Med 2020; 24 (8):731-734.

DOI: 10.5005/jp-journals-10071-23541

License: CC BY-NC 4.0

Published Online: 21-09-2020

Copyright Statement:  Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Polymyositis (PM) is an uncommon inflammatory myopathy that affects striated muscles. It causes weakness of the limb girdles, neck, and pharyngeal muscles. We are presenting a case of PM which manifested after intrauterine death (IUD). The patient was referred to our hospital for breathing difficulty, 4 days after delivery of a dead fetus. Initially, she was treated in line of puerperal sepsis and peripartum cardiomyopathy. Patient\'s cardiopulmonary functions improved but she had persistent high-grade fever. Gross muscle weakness was found on day 5 of admission, involving all four limbs, predominantly in proximal muscles and she had dark colored urine. Laboratory tests revealed myoglobinuria, high serum creatine phosphokinase (CPK) levels, and high lactate dehydrogenase (LDH) levels. Polymyositis diagnosed on the basis of high CPK levels, magnetic resonance imaging (MRI) of cervical spine, electromyography (EMG), and muscle biopsy findings. We question, whether the PM could be pathogenically related to the pregnancy? Literature review of the previously reported cases of PM/dermatomyositis and our case report suggests that pregnancy can trigger the new onset of PM.


PDF Share
  1. O'Hanlon TP, Miller FW. Genetic risk and protective factor for the idiopathic inflammatory myopathies. Curr Rheumatol Rep 2009;11(4):287–294. DOI: 10.1007/s11926-009-0040-2.
  2. Dobloug C, Garen T, Bitter H, Stjärne J, Stenseth G, Grøvle L, et al. prevalence and clinical characteristics of adult polymyositis and dermatomyositis; Data from a large and unselected Norwegian cohort. Ann Rheum Dis 2015;74(8):1551–1556. DOI: 10.1136/annrheumdis-2013-205127.
  3. Bohan A. History and classification of polymyositis and dermatomyositis. Clin Dermatol 1988;6(2):3–8. DOI: 10.1016/0738-081X(88)90044-2.
  4. Khamashta MA, Ruiz-Irastorza G, Hughes GRV. Systemic lupus erythematosus flares during pregnancy. Rheum Dis Clin North Am 1997;23(1):15–30. DOI: 10.1016/S0889-857X(05)70312-4.
  5. Steen VD. Scleroderma and pregnancy. Rheum Dis Clin North Am 1997;23(1):133–147. DOI: 10.1016/S0889-857X(05)70319-7.
  6. Fraser D, Turner JWA. Myasthenia gravis and pregnancy. Proc R Soc Med 1963;56(5):379–381. DOI: 10.1177/003591576305600523.
  7. Korn-Lubetzki I, Kahana E, Cooper G, Abramsky O. Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol 1984;16(2):229–231. DOI: 10.1002/ana.410160211.
  8. Nelson JL. Pregnancy, immunology and autoimmune disease. J Reprod Med 1998;43(4):335–340.
  9. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996;93(2):705–708. DOI: 10.1073/pnas.93.2.705.
  10. Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A, et al. Microchimerism and HLA compatible relationships of pregnancy in scleroderma. Lancet 1998;351(9102):559–562. DOI: 10.1016/S0140-6736(97)08357-8.
  11. Katz SI. Herpes gestationis. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al., ed. Dermatology in General Medicine. 4th edn., New York: McGraw-Hill; 1993. pp. 626–629.
  12. Pinheiro GdaR, Goldenberg J, Atra E, Pereira RB, Camano L, Schmidt B. Juvenile dermatomyositis and pregnancy: report and literature review. J Rheumatol 1992;19(11):1798–1801.
  13. Gutierrez G, Dagnino R, Mintz G. Polymyositis/dermatomyositis and pregnancy. Arthritis Rheum 1984;27(3):291–294. DOI: 10.1002/art.1780270307.
  14. Silva CA, Sultan SM, Isenberg DA. Pregnancy outcome in adult-onset idiopathic inflammatory myopathy. Rheumatology (Oxford) 2003;42(10):1168–1172. DOI: 10.1093/rheumatology/keg318.
  15. Steiner I, Averbuch-Heller L, Abramsky O, Raz E. Postpartum idiopathic polymyositis. Lancet 1992;339(8787):256. DOI: 10.1016/0140-6736(92)90073-C.
  16. Missumi LS, Souza FH, Andrade JQ, Shinjo SK. Pregnancy outcomes in dermatomyositis and polymyositis patients. Rev Bras Reumatol 2015;55(2):95–102. DOI: 10.1016/j.rbr.2014.10.001.
  17. Takei R, Suzuki S, Kijima K, Sawa R, Yoneyama Y, Asakura H, et al. First presentation of polymyositis postpartum following intrauterine fetal death. Arch Gynecol Obstet 2000;264(1):47–48. DOI: 10.1007/PL00007487.
  18. Noelyn AH, Christopher J, Martha N, Highton J. Pregnancy related polymyositis and massive perivillous fibrin deposition in the placenta: are they pathogenetically related? Arthritis Rheum 2006;55(1):154–156. DOI: 10.1002/art.21710.
  19. Papapetropoulos T, Kanellakopoulou N, Tsibri E, Paschalis C. Polymyositis and pregnancy: report of a case with three pregnancies. J Neurol Neurosurg Psychiatry 1998;64(3):406. DOI: 10.1136/jnnp.64.3.406.
  20. Kanoh H, Izumi T, Seishima M, Nojiri M, Ichiki Y, Kitajima Y. A case of dermatomyositis that developed after delivery: the involvement of pregnancy in the induction of dermatomyositis. Br J Dermatol 1999;141(5):897–900. DOI: 10.1046/j.1365-2133.1999.03165.x.
  21. Lee SI, Yoo WH. Postpartum-onset dermatomyositis: case report and literature review. Mod Rheumatol 2002;12(4):362–365. DOI: 10.3109/s101650200066.
  22. Yassaee M, Kovarik CL, Werth VP. Pregnancy-associated dermatomyositis. Arch Dermatol 2009;145(8):952–953.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.